Skip to main content

Table 5 Multivariate analysis for TTFT and OS

From: Extensive next-generation sequencing analysis in chronic lymphocytic leukemia at diagnosis: clinical and biological correlations

 

TTFT

OS

 

After bootstrapping

  

After bootstrapping

Variable

HR

CI

p

CI

p

HR

CI

p

CI

p

Binet stage b–c vs a

11.206

6.384–19.671

<0.001

5.570–22.545

<0.001

3.080

1.501–6.319

0.002

1.302–7.286

0.010

CD38 pos vs neg

1.141

0.670–1.942

0.627

0.663–1.938

0.634

1.067

0.506–2.249

0.864

0.448–2.356

0.883

11q deletion yes vs no

1.306

0.619–2.755

0.484

0.532–3.205

0.560

Na

Na

Na

Na

Na

TP53 disruption yes vs no

2.255

1.168–4.352

0.015

1.039–4.891

0.040

4.055

1.844–7.917

<0.001

1.897–8.670

<0.001

IGHV unmut vs mut

5.078

2.599–9.554

<0.001

2.491–10.354

<0.001

3.198

1.524–6.13

0.002

1.200–8.522

0.020

No. of mutations by NGS

 0

1

  

1

 

1

  

1

 

 1

1.452

0.812–2.594

0.208

0.574–3.673

0.431

0.930

0.417–2.074

0.860

0.348–2.484

0.885

 ≥2

2.791

1.468–5.306

0.002

1.375–5.665

0.004

1.115

0.492–2.523

0.795

0.480–2.589

0.801

Complex karyotype yes vs no

1.649

0.896–3.034

0.108

0.824–3.301

0.158

3.173

1.521–6.619

0.002

1.369–7.355

0.007

  1. f female, fav favorable, int intermediate, m male, mut mutated, neg negative, pos positive, unfav unfavorable, unmut unmutated, yrs years, TP53 disruption 17p13 deletion and/or TP53 mutation